In this week's video, Dr. Brian Durie discusses if the newly FDA-approved drugs (Ninlaro, Empliciti, Darzalex) be available for frontline therapy?

Bottom Line:

When to use the new drugs requires a case-by-case discussion, with possible use in early disease stages.

Previous Post
To collaborate, or not to collaborate, that is the question
Next Post
Can myeloma progress after an autologous stem cell transplant (ASCT)?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.